Chemical Structure : LL-K8-22
CAS No.: 3034487-84-5
Catalog No.: PC-20323Not For Human Use, Lab Use Only.
LL-K8-22 is a potent, selective dual degrader of of CDK8 and cyclin C (MDA-MB-468 cell DC50, 2.52 and 2.64 uM), significantly degrades CDK8 without reducing CDK19 and does not degrade other cyclin proteins.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $358 | In stock | |
10 mg | $548 | In stock | |
25 mg | $898 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
LL-K8-22 is a potent, selective dual degrader of of CDK8 and cyclin C (MDA-MB-468 cell DC50, 2.52 and 2.64 uM), significantly degrades CDK8 without reducing CDK19 and does not degrade other cyclin proteins.
LL-K8-22 showed enhanced anti-proliferative effects over its parental molecule BI-1347.
LL-K8-22 exhibited more pronounced effects on CDK8–cyclin C downstream signaling than BI-1347, suppressing STAT1 phosphorylation more persistently.
LL-K8-22 inhibited E2F- and MYC-driven carcinogenic transcriptional programs.
M.Wt | 573.79 | |
Formula | C37H43N5O | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
1-(4-(3-((3r,5r,7r)-Adamantan-1-yl)propyl)piperazin-1-yl)-2-(4-(4-(isoquinolin-4-yl)phenyl)-1H-pyrazol-1-yl)ethan-1-one |
1. Mingyu Wang, et al. J Med Chem. 2023 Mar 17. doi: 10.1021/acs.jmedchem.2c02045.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright